X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8011) 8011
Publication (661) 661
Book Review (99) 99
Newsletter (71) 71
Book Chapter (61) 61
Book / eBook (13) 13
Conference Proceeding (13) 13
Dissertation (13) 13
Magazine Article (10) 10
Government Document (2) 2
Newspaper Article (2) 2
Paper (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4564) 4564
heparin (3377) 3377
animals (2739) 2739
index medicus (2361) 2361
male (1924) 1924
female (1527) 1527
heparin - pharmacology (1457) 1457
anticoagulants (1180) 1180
heparin - therapeutic use (983) 983
hematology (970) 970
anticoagulants - therapeutic use (960) 960
biochemistry & molecular biology (935) 935
middle aged (880) 880
molecular-weight heparin (804) 804
rats (796) 796
peripheral vascular disease (780) 780
glycosaminoglycans (761) 761
aged (744) 744
heparin - analogs & derivatives (738) 738
pharmacology & pharmacy (708) 708
mice (668) 668
heparin - chemistry (656) 656
adult (629) 629
heparin - metabolism (626) 626
anticoagulants - pharmacology (590) 590
binding (549) 549
thrombosis (535) 535
heparin - administration & dosage (527) 527
anticoagulants - administration & dosage (506) 506
cardiac & cardiovascular systems (505) 505
analysis (464) 464
heparin - adverse effects (463) 463
anticoagulants - adverse effects (459) 459
treatment outcome (451) 451
kinetics (436) 436
proteins (434) 434
fibrinolytic agents - therapeutic use (429) 429
platelet aggregation inhibitors - therapeutic use (426) 426
dose-response relationship, drug (425) 425
ticlopidine - analogs & derivatives (421) 421
thrombin (419) 419
hirudins - analogs & derivatives (418) 418
cells, cultured (408) 408
unfractionated heparin (405) 405
protein binding (401) 401
research (392) 392
time factors (391) 391
molecular sequence data (386) 386
heparin, low-molecular-weight - therapeutic use (374) 374
sulfates (374) 374
molecular weight (370) 370
blood coagulation - drug effects (368) 368
cell biology (361) 361
inhibition (360) 360
recombinant proteins - therapeutic use (357) 357
risk factors (353) 353
derivatives (351) 351
article (347) 347
venous thromboembolism (347) 347
cancer (344) 344
drug therapy, combination (335) 335
surgery (332) 332
in-vitro (329) 329
materials science, biomaterials (326) 326
binding sites (323) 323
prevention (318) 318
thrombin - antagonists & inhibitors (317) 317
chemistry, organic (316) 316
chemistry, multidisciplinary (305) 305
sulfate (305) 305
angiogenesis (304) 304
aspirin - therapeutic use (299) 299
engineering, biomedical (296) 296
in vitro techniques (293) 293
deep-vein thrombosis (290) 290
therapy (284) 284
cattle (282) 282
activation (278) 278
ticlopidine - therapeutic use (277) 277
oncology (276) 276
rabbits (275) 275
cells (271) 271
thrombocytopenia - chemically induced (265) 265
structure-activity relationship (264) 264
care and treatment (258) 258
medicine & public health (258) 258
heparan sulfate (255) 255
thromboembolism (255) 255
amino acid sequence (254) 254
partial thromboplastin time (254) 254
coagulation (251) 251
cell line (247) 247
anticoagulation (245) 245
heparin-induced thrombocytopenia (243) 243
polysaccharides (243) 243
hirudin therapy (239) 239
health aspects (238) 238
thrombosis - prevention & control (235) 235
aspirin (234) 234
anticoagulants - chemistry (232) 232
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7772) 7772
German (117) 117
French (108) 108
Japanese (81) 81
Russian (67) 67
Italian (25) 25
Spanish (25) 25
Chinese (12) 12
Hungarian (8) 8
Polish (8) 8
Dutch (7) 7
Ukrainian (5) 5
Czech (4) 4
Portuguese (3) 3
Bulgarian (2) 2
Finnish (2) 2
Korean (1) 1
Norwegian (1) 1
Romanian (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Cellular Physiology, ISSN 0021-9541, 09/2019, Volume 234, Issue 9, pp. 15438 - 15449
Unfractionated heparin (UFH) and low molecular heparin derivatives (LMWH) display numerous biological properties in addition to their anticoagulant effects.... 
heparin | low molecular heparin derivatives | podocyte permeability | podocyte | Albumin | Anticoagulants (Medicine) | Permeability | Analysis | Cells | Biological properties | Heterogeneity | Anticoagulants | Morphology | Membrane permeability | Cytoskeleton | Extracellular matrix | Heparin | Derivatives | In vitro methods and tests | Heparins
Journal Article
Journal Article
Archiv der Pharmazie, ISSN 0365-6233, 02/2020, Volume 353, Issue 2, pp. e1900231 - n/a
Journal Article
Heterocycles, ISSN 0385-5414, 2015, Volume 91, Issue 11, pp. 2113 - 2125
An efficient protocol for the synthesis of novel glycosyl thiazole derivatives starting from the commercially available D-glucosamine hydrochloride was... 
2-AMINOTHIAZOLE DERIVATIVES | OLIGOSACCHARIDES | ANALOGS | CHEMISTRY, ORGANIC | HEPARIN | D-Glucosamine | Glycosylthiourea | AGENTS | Glycosyl Isothiocyanate | OSTEOARTHRITIS | INHIBITORS | Thiazole | GLYCOBIOLOGY | CHLORIDE
Journal Article
Journal of Colloid And Interface Science, ISSN 0021-9797, 07/2016, Volume 474, pp. 9 - 17
Journal Article
Molecules (Basel, Switzerland), ISSN 1420-3049, 01/2020, Volume 25, Issue 2, p. 390
This review comes as a part of the special issue "Emerging frontiers in GAGs and mimetics". Our interest is in the manipulation of heparan sulfate (HS)... 
mucopolysaccharidosis | heparanase | cancer | heparan sulfate | neurodegenerative disorders | heparin derivatives
Journal Article